Atlas Trials

Evaluation and Modeling of the Effect of G-CSF on the Evolution of Polynuclear Neutrophils During Dense Dose Epirubicin-Cyclophosphamide Regeneration

Clinical trial NCT05296317 · COMPLETED

Trial details

NCT number
NCT05296317
Sponsor
Centre Georges Francois Leclerc
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Localized Breast Cancer
Start date
2022-09-02
Primary completion
2025-09-26
Enrollment
97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.